Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery

Byung Soo Kim, Seung-Woo Cho, Il Kwon Kim, Jin Muk Kang, Kang Won Song, Hong Sik Kim, Chang Hwan Park, Kyung Jong Yoo

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no growth potential. Tissue-engineered vascular grafts (TEVGs) may solve this problem. In this study, we developed a TEVG using autologous bone marrow-derived cells (BMCs) and decellularized tissue matrices, and tested whether the TEVGs exhibit growth potential and vascular remodeling in vivo. Vascular smooth muscle-like cells and endothelial-like cells were differentiated from bone marrow mononuclear cells in vitro. TEVGs were fabricated by seeding these cells onto decellularized porcine abdominal aortas and implanted into the abdominal aortas of 4-month-old, bone marrow donor pigs (n = 4). Eighteen weeks after implantation, the dimensions of TEVGs were measured and compared with those of native abdominal aortas. Expression of molecules associated with vascular remodeling was examined with reverse transcription-polymerase chain reaction assay and immunohistochemistry. Eighteen weeks after implantation, all TEVGs were patent with no sign of thrombus formation, dilatation, or stenosis. Histological and immunohistochemical analyses of the retrieved TEVGs revealed regeneration of endothelium and smooth muscle and the presence of collagen and elastin. The outer diameter of three of the four TEVGs increased in proportion to increases in body weight and outer native aorta diameter. Considerable extents of expression of molecules associated with extracellular matrix (ECM) degradation (i.e., matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase) and ECM precursors (i.e., procollagen I, procollagen III, and tropoelastin) occurred in the TEVGs, indicating vascular remodeling associated with degradation of exogenous ECMs (implanted decellularized matrices) and synthesis of autologous ECMs. This study demonstrates that the TEVGs with autologous BMCs and decellularized tissue matrices exhibit growth potential and vascular remodeling in vivo of tissue-engineered artery.

Original languageEnglish
Pages (from-to)901-912
Number of pages12
JournalTissue Engineering - Part A
Volume15
Issue number4
DOIs
Publication statusPublished - 2009 Apr 1

Fingerprint

Blood Vessel Prosthesis
Arteries
Grafts
Tissue
Growth
Abdominal Aorta
Bone Marrow Cells
Procollagen
Bone
Military electronic countermeasures
Extracellular Matrix
Swine
Tropoelastin
Vascular Remodeling
Tissue Inhibitor of Metalloproteinases
Muscle
Matrix Metalloproteinase Inhibitors
Cardiovascular surgery
Elastin
Matrix Metalloproteinases

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Biochemistry
  • Biomaterials
  • Biomedical Engineering

Cite this

Kim, Byung Soo ; Cho, Seung-Woo ; Kim, Il Kwon ; Kang, Jin Muk ; Song, Kang Won ; Kim, Hong Sik ; Park, Chang Hwan ; Yoo, Kyung Jong. / Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery. In: Tissue Engineering - Part A. 2009 ; Vol. 15, No. 4. pp. 901-912.
@article{246af69591104934bcdd4e8cdd20c291,
title = "Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery",
abstract = "Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no growth potential. Tissue-engineered vascular grafts (TEVGs) may solve this problem. In this study, we developed a TEVG using autologous bone marrow-derived cells (BMCs) and decellularized tissue matrices, and tested whether the TEVGs exhibit growth potential and vascular remodeling in vivo. Vascular smooth muscle-like cells and endothelial-like cells were differentiated from bone marrow mononuclear cells in vitro. TEVGs were fabricated by seeding these cells onto decellularized porcine abdominal aortas and implanted into the abdominal aortas of 4-month-old, bone marrow donor pigs (n = 4). Eighteen weeks after implantation, the dimensions of TEVGs were measured and compared with those of native abdominal aortas. Expression of molecules associated with vascular remodeling was examined with reverse transcription-polymerase chain reaction assay and immunohistochemistry. Eighteen weeks after implantation, all TEVGs were patent with no sign of thrombus formation, dilatation, or stenosis. Histological and immunohistochemical analyses of the retrieved TEVGs revealed regeneration of endothelium and smooth muscle and the presence of collagen and elastin. The outer diameter of three of the four TEVGs increased in proportion to increases in body weight and outer native aorta diameter. Considerable extents of expression of molecules associated with extracellular matrix (ECM) degradation (i.e., matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase) and ECM precursors (i.e., procollagen I, procollagen III, and tropoelastin) occurred in the TEVGs, indicating vascular remodeling associated with degradation of exogenous ECMs (implanted decellularized matrices) and synthesis of autologous ECMs. This study demonstrates that the TEVGs with autologous BMCs and decellularized tissue matrices exhibit growth potential and vascular remodeling in vivo of tissue-engineered artery.",
author = "Kim, {Byung Soo} and Seung-Woo Cho and Kim, {Il Kwon} and Kang, {Jin Muk} and Song, {Kang Won} and Kim, {Hong Sik} and Park, {Chang Hwan} and Yoo, {Kyung Jong}",
year = "2009",
month = "4",
day = "1",
doi = "10.1089/ten.tea.2008.0172",
language = "English",
volume = "15",
pages = "901--912",
journal = "Tissue Engineering - Part A.",
issn = "1937-3341",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery. / Kim, Byung Soo; Cho, Seung-Woo; Kim, Il Kwon; Kang, Jin Muk; Song, Kang Won; Kim, Hong Sik; Park, Chang Hwan; Yoo, Kyung Jong.

In: Tissue Engineering - Part A, Vol. 15, No. 4, 01.04.2009, p. 901-912.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery

AU - Kim, Byung Soo

AU - Cho, Seung-Woo

AU - Kim, Il Kwon

AU - Kang, Jin Muk

AU - Song, Kang Won

AU - Kim, Hong Sik

AU - Park, Chang Hwan

AU - Yoo, Kyung Jong

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no growth potential. Tissue-engineered vascular grafts (TEVGs) may solve this problem. In this study, we developed a TEVG using autologous bone marrow-derived cells (BMCs) and decellularized tissue matrices, and tested whether the TEVGs exhibit growth potential and vascular remodeling in vivo. Vascular smooth muscle-like cells and endothelial-like cells were differentiated from bone marrow mononuclear cells in vitro. TEVGs were fabricated by seeding these cells onto decellularized porcine abdominal aortas and implanted into the abdominal aortas of 4-month-old, bone marrow donor pigs (n = 4). Eighteen weeks after implantation, the dimensions of TEVGs were measured and compared with those of native abdominal aortas. Expression of molecules associated with vascular remodeling was examined with reverse transcription-polymerase chain reaction assay and immunohistochemistry. Eighteen weeks after implantation, all TEVGs were patent with no sign of thrombus formation, dilatation, or stenosis. Histological and immunohistochemical analyses of the retrieved TEVGs revealed regeneration of endothelium and smooth muscle and the presence of collagen and elastin. The outer diameter of three of the four TEVGs increased in proportion to increases in body weight and outer native aorta diameter. Considerable extents of expression of molecules associated with extracellular matrix (ECM) degradation (i.e., matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase) and ECM precursors (i.e., procollagen I, procollagen III, and tropoelastin) occurred in the TEVGs, indicating vascular remodeling associated with degradation of exogenous ECMs (implanted decellularized matrices) and synthesis of autologous ECMs. This study demonstrates that the TEVGs with autologous BMCs and decellularized tissue matrices exhibit growth potential and vascular remodeling in vivo of tissue-engineered artery.

AB - Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no growth potential. Tissue-engineered vascular grafts (TEVGs) may solve this problem. In this study, we developed a TEVG using autologous bone marrow-derived cells (BMCs) and decellularized tissue matrices, and tested whether the TEVGs exhibit growth potential and vascular remodeling in vivo. Vascular smooth muscle-like cells and endothelial-like cells were differentiated from bone marrow mononuclear cells in vitro. TEVGs were fabricated by seeding these cells onto decellularized porcine abdominal aortas and implanted into the abdominal aortas of 4-month-old, bone marrow donor pigs (n = 4). Eighteen weeks after implantation, the dimensions of TEVGs were measured and compared with those of native abdominal aortas. Expression of molecules associated with vascular remodeling was examined with reverse transcription-polymerase chain reaction assay and immunohistochemistry. Eighteen weeks after implantation, all TEVGs were patent with no sign of thrombus formation, dilatation, or stenosis. Histological and immunohistochemical analyses of the retrieved TEVGs revealed regeneration of endothelium and smooth muscle and the presence of collagen and elastin. The outer diameter of three of the four TEVGs increased in proportion to increases in body weight and outer native aorta diameter. Considerable extents of expression of molecules associated with extracellular matrix (ECM) degradation (i.e., matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase) and ECM precursors (i.e., procollagen I, procollagen III, and tropoelastin) occurred in the TEVGs, indicating vascular remodeling associated with degradation of exogenous ECMs (implanted decellularized matrices) and synthesis of autologous ECMs. This study demonstrates that the TEVGs with autologous BMCs and decellularized tissue matrices exhibit growth potential and vascular remodeling in vivo of tissue-engineered artery.

UR - http://www.scopus.com/inward/record.url?scp=67049136591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049136591&partnerID=8YFLogxK

U2 - 10.1089/ten.tea.2008.0172

DO - 10.1089/ten.tea.2008.0172

M3 - Article

VL - 15

SP - 901

EP - 912

JO - Tissue Engineering - Part A.

JF - Tissue Engineering - Part A.

SN - 1937-3341

IS - 4

ER -